Using the above approach, we observed enhanced proliferation of pmel CD8+ T cells (compared with vehicle-treated cells), as reflected by an increase in the CFSE dilution (CFSElow) in the draining lymph nodes of MQ pre-treated tumors (Fig 1B), suggesting that MQ treatment can increase tumor immunogenicity. The gene discussed is CD8A; the disease is neoplasm.